In patients with: Acute hepatitis and active cirrhosis; Liver disorders previously associated with methyldopa therapy; Disease of pheochromocytoma; People who are taking monoamine oxidase (MAO) inhibitors; Nursing woman; Hypersensitivity to any component of this preparation.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
